Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,706 | 1,039 | 98.6% |
| Education | $163.03 | 9 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,809 | 60 | $0 (2023) |
| Novo Nordisk Inc | $1,575 | 158 | $0 (2023) |
| Lilly USA, LLC | $996.62 | 86 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $953.48 | 86 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $896.12 | 78 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $687.57 | 77 | $0 (2023) |
| PFIZER INC. | $656.59 | 76 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $609.78 | 63 | $0 (2023) |
| Allergan, Inc. | $569.29 | 90 | $0 (2020) |
| GlaxoSmithKline, LLC. | $511.86 | 49 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,336 | 107 | Boehringer Ingelheim Pharmaceuticals, Inc. ($291.61) |
| 2022 | $1,424 | 99 | AstraZeneca Pharmaceuticals LP ($267.84) |
| 2021 | $1,987 | 168 | AbbVie Inc. ($397.75) |
| 2020 | $1,714 | 153 | Novo Nordisk Inc ($263.75) |
| 2019 | $1,552 | 147 | AstraZeneca Pharmaceuticals LP ($294.55) |
| 2018 | $2,080 | 221 | Takeda Pharmaceuticals U.S.A., Inc. ($324.52) |
| 2017 | $1,776 | 153 | Janssen Pharmaceuticals, Inc ($367.06) |
All Payment Transactions
1,048 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: Gastroenterology | ||||||
| 12/14/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $5.18 | General |
| Category: Gastroenterology | ||||||
| 12/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $10.22 | General |
| 12/11/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.86 | General |
| Category: Diabetes | ||||||
| 12/05/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Diabetes | ||||||
| 12/04/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Respiratory | ||||||
| 11/29/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $3.64 | General |
| Category: Gastroenterology | ||||||
| 11/27/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $9.41 | General |
| 11/15/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: VACCINES | ||||||
| 11/07/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.46 | General |
| Category: Obesity | ||||||
| 11/06/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Respiratory | ||||||
| 11/03/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Diabetes | ||||||
| 11/02/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $3.89 | General |
| 11/01/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: Gastroenterology | ||||||
| 10/31/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.92 | General |
| Category: Gastroenterology | ||||||
| 10/25/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: Gastroenterology | ||||||
| 10/24/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Cardio-renal | ||||||
| 10/19/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.62 | General |
| Category: Diabetes | ||||||
| 10/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $6.36 | General |
| 10/17/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/13/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $3.36 | General |
| Category: Obesity | ||||||
| 10/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: Diabetes | ||||||
| 10/11/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,334 | 2,096 | $273,995 | $109,945 |
| 2022 | 13 | 1,132 | 1,727 | $248,685 | $103,857 |
| 2021 | 14 | 1,124 | 1,963 | $245,578 | $96,818 |
| 2020 | 13 | 1,122 | 1,921 | $233,659 | $82,165 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87880 | Strep test (streptococcus, group a) | Office | 2020 | 16 | 17 | $765.00 | $277.38 | 36.3% |
| 81003 | Automated urinalysis test | Office | 2020 | 49 | 70 | $1,400 | $156.50 | 11.2% |
About Dr. Troy D'amour, DO
Dr. Troy D'amour, DO is a Family Medicine healthcare provider based in Joplin, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376589804.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Troy D'amour, DO has received a total of $11,869 in payments from pharmaceutical and medical device companies, with $1,336 received in 2023. These payments were reported across 1,048 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($11,706).
As a Medicare-enrolled provider, D'amour has provided services to 4,712 Medicare beneficiaries, totaling 7,707 services with total Medicare billing of $392,785. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Joplin, MO
- Active Since 06/22/2006
- Last Updated 12/21/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1376589804
Products in Payments
- Ozempic (Drug) $967.49
- XIFAXAN (Drug) $653.16
- BREZTRI (Drug) $617.43
- FARXIGA (Drug) $597.19
- TRULICITY (Drug) $498.65
- VRAYLAR (Drug) $498.45
- XARELTO (Drug) $475.35
- SYMBICORT (Drug) $424.47
- INVOKANA (Drug) $414.75
- JARDIANCE (Drug) $352.41
- TRELEGY ELLIPTA (Drug) $319.52
- TRADJENTA (Drug) $273.75
- Trintellix (Drug) $272.56
- JANUVIA (Drug) $265.32
- Victoza (Drug) $252.42
- CHANTIX (Drug) $245.90
- STIOLTO RESPIMAT (Drug) $245.34
- TRINTELLIX (Drug) $243.30
- Rybelsus (Drug) $217.20
- UBRELVY (Drug) $214.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Joplin
Dr. Luke Wicke, Do, DO
Family Medicine — Payments: $14,984
Dr. Maria Fe Bruce, Md, MD
Family Medicine — Payments: $12,947
James Dailey, D.o, D.O
Family Medicine — Payments: $9,990
Sean Pfeffer, Md, MD
Family Medicine — Payments: $9,746
William Hughes, Do, DO
Family Medicine — Payments: $7,047
Amanda Andrade, Do, DO
Family Medicine — Payments: $6,472